Showing results (121-130 of 1,154) with videos related to
Sort By:
Pageof 116
Revista Espanola De Cardiologia|May 21, 2004
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]Dominick J Angiolillo, Luigi M Biasucci, Giovanna Liuzzo, et al.Current Vascular Pharmacology|March 20, 2013
Microvascular obstruction after primary percutaneous coronary intervention: pathogenesis, diagnosis and prognostic significanceGiampaolo Niccoli, Nicola Cosentino, Silvia Minelli, et al.International Journal of Cardiology|July 26, 2018
Contrast Fractional Flow Reserve (cFFR): A pragmatic response to the call for simplification of invasive functional assessmentAntonio Maria Leone, Francesca Lassandro Pepe, Manfredi Arioti, et al.Journal of Molecular and Cellular Cardiology|April 19, 2024
An update on the mechanisms of Takotsubo syndrome: "At the end an acute coronary syndrome"Filippo Crea, Giulia Iannaccone, Giulia La Vecchia, et al.American Heart Journal|November 24, 2019
Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million peopleAldo P Maggioni, Letizia Dondi, Felicita Andreotti, et al.Recenti Progressi in Medicina|February 13, 2009
[Association between ethanol intake and ischemic heart disease]Giampaolo Niccoli, Marco Bacà, Nicola Cosentino, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 3, 2005
Interplay of platelet polymorphisms, risk factors, and von [corrected] Willebrand factor [corrected] in determining collagen-adenosine diphosphate PFA-100 results in patients with coronary artery diseaseItalo Porto, Antonio Maria Leone, Luisa Nanni, et al.Heart (British Cardiac Society)|October 16, 2007
IgA anticardiolipin antibody is associated with the extent of daily-life ischaemia in patients with chronic coronary artery diseaseIgnatios Ikonomidis, John Lekakis, Georgia Vamvakou, et al.Giornale Italiano Di Cardiologia (2006)|November 27, 2014
[Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]Davide Imberti, Giancarlo Agnelli, Felicita Andreotti, et al.Journal of Thrombosis and Thrombolysis|July 31, 2008
Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasisVincent M G Maher, Yuri Kitano, Clare Neuwirth, et al.Pageof 116